The process by which clinical trial agreements (CTAs) are developed often has a tremendous impact on study start-up – affecting site-level budgets, payment terms, and Clinical Trial Management Systems (CTMS) set-up. There are many challenges involved in executing global CTAs and, in turn, performing investigator payments in clinical research, but a number of these challenges can be averted with proper planning and execution in the budget development stage.
Read this white paper to understand the most important considerations for a fully-integrated process that results in high-efficiency enabled contracts and payments.
Most Recent Flipbooks
Studies show clinical trial participants want to know what was learned from their involvement. Many sponsors are implementing plans to deliver plain language summaries to trial participants.
Written Procedures for IRBs: What Does the New Final Guidance from FDA and OHRP Mean to You?
Avoid Enrollment Pitfalls: Find Your Best-fit Clinical Trial Sites
Selecting the right site is the single most crucial decision you’ll make about your next clinical trial. And perhaps the single most important consideration in selecting a site is whether it can make
Six Practices of High Performing Clinical Research Sites
Learn what high-performing research sites have in common, and what makes sponsors return to them again and again.
Looking Ahead to 2018: Insights into Clinical Research Trends from Our Experts
In this paper, WCG thought-leaders provide insights on what they anticipate in 2018 in clinical trial technology, regulatory changes, and scientific developments.
Gene Therapy & Immunotherapy Glossary, 2nd Edition
The Second Edition of WCG’s wildly popular Alphabetical Glossary of Terms in Gene Therapy and Immunotherapy.
Investigational Drugs Outside of Clinical Trials - Understanding Expanded Access and Right-to-Try
Managing the Unmanageable: Meeting the Challenge of Appropriate Safety Report Distribution